The long-term effect of coronary stenting on epicardial and microvascular endothelial function

Seong-Hoon Lim1, Andreas J Flammer, Myeong Ho Yoon

  • 1Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

Insights

Coronary stents do not significantly impact microvascular function long-term. Epicardial and microcirculatory function in stented patients were similar to controls with non-significant coronary artery disease.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Drug-eluting stents (DES) and bare-metal stents (BMS) are linked to epicardial endothelial dysfunction.
  • Long-term effects of coronary stenting on microvascular function remain unclear.

Purpose of the Study:

  • To investigate the long-term impact of coronary stenting on both epicardial and microvascular endothelial function.
  • To compare vascular function in patients with coronary stents to a control group with similar symptoms but no prior intervention.

Main Methods:

  • Evaluated 71 patients with prior stenting (LAD) and 71 matched controls with chest pain and non-significant coronary artery disease.
  • Assessed coronary microvascular function using coronary flow reserve (CFR) with intracoronary adenosine.
  • Measured epicardial endothelial function via quantitative coronary angiography response to acetylcholine.

Main Results:

  • No significant difference in microcirculatory function (CFR) between stented and control groups (P=0.24).
  • Epicardial endothelial dysfunction was present in both groups (-23.0% vs -20.0%, P=0.4).
  • No significant difference in outcomes between DES and BMS patients.

Conclusions:

  • Coronary stenting does not significantly alter long-term coronary microcirculatory function.
  • Epicardial and microcirculatory function in stented patients are comparable to individuals with similar symptoms but non-significant coronary artery disease.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...